12 completed, 2 recruiting, 2 unknown, 1 terminated. 17 Phase 2, 6 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 12, Recruiting 2, Unknown 2, Terminated 1 |
| Phase 3 | 6 | Completed 4, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Lactulose: new trials by email Literature Review of Lactulose trials Research Report on Lactulose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy Lactulose - Cancer | Phase 1 / Phase 2 | Recruiting | University of Chicago | 55 | 2026-12-15 | 2026-06-16 |
| Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis Clotrimazole+Lactulose., Canesten (Clotrimazole), Lactulose - Candidal Vulvovaginitis (ICD-10 Code: B37.3), Vulvovaginal Candidiasis (VVC) | Phase 2 / Phase 3 | Recruiting | AVVA Pharmaceuticals Ltd. | 264 | 2024-02-29 | 2025-02-19 |
| Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial Polyethylene Glycol, Isabgol + Lactulose - Anal Fissure, Constipation | Phase 2 / Phase 3 | Completed | All India Institute of Medical Sciences, Bhubaneswar | 144 | 2022-05-27 | 2023-07-25 |
| A Trial to Improve Quality of Life in People With Cirrhosis Lactulose - Cirrhosis | Phase 2 / Phase 3 | Completed | University of Michigan | 56 | 2021-11-10 | 2023-11-21 |
| Effect of Probiotic on Gut Microbiota in Young Children With Functional Constipation Probiotic, Lactulose Oral Liquid Product, probiotic + lactulose - Functional Constipation in Children | Phase 2 | Completed | Min-Tze LIONG | 84 | 2020-06-10 | 2026-04-07 |
| Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy Nitazoxanide, Lactulose - Encephalopathy, Hepatic | Phase 2 / Phase 3 | Unknown | Sherief Abd-Elsalam | 120 | 2016-01-01 | 2017-08-21 |
| The Effects of Nitazoxanide in Hepatic Encephalopathy Nitazoxanide, Oral lactulose, Metronidazole - Hepatic Encephalopathy | Phase 2 | Unknown | Ain Shams University | 36 | 2014-12-01 | 2015-01-08 |
| A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in Adults Lactofiltrum, Placebo - Atopic Dermatitis | Phase 2 / Phase 3 | Completed | Avva Rus, JSC | 90 | 2010-05-01 | 2010-09-14 |
| Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life VSL#3, Lactulose - Chronic Liver Disease, Hepatic Encephalopathy | Phase 2 / Phase 3 | Completed | CD Pharma India Pvt. Ltd. | 120 | 2009-10-01 | 2013-06-04 |
| Study of Lactulose in Children With Chronic Liver Disease Lactulose, placebo - Minimal Hepatic Encephalopathy | Phase 2 | Terminated | Indiana University | 16 | 2009-01-01 | 2014-02-10 |
| A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation deep needling, Lactulose, shallow needling - Constipation | Phase 2 | Completed | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 475 | 2008-04-01 | 2014-06-04 |
| Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy AST-120, lactulose - Hepatic Encephalopathy | Phase 2 | Completed | Ocera Therapeutics | 40 | 2007-09-01 | 2014-05-30 |
| Lactulose Supplementation in Premature Infants Lactulose, Dextrose - Necrotizing Enterocolitis, Sepsis | Phase 2 | Completed | Bnai Zion Medical Center | 28 | 2005-02-01 | 2008-02-15 |
| Movicol in Childhood Constipation (ProMotion Study) Polyethylene glycol 3350 NA bicarbonate NaCl KCl (Movicol), Lactulose - Feces, Impacted | Phase 2 | Completed | Norgine | 60 | 2000-10-01 | 2007-01-04 |
| Movicol in Childhood Constipation (ProMotion Study) Polyethylene glycol 3350 NA bicarbonate NaCl KCl (Movicol), Lactulose - Chronic Constipation | Phase 2 | Completed | Norgine | 60 | 2000-10-01 | 2006-11-28 |
| Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis lactulose - Portal Hypertension, Hepatic Encephalopathy | Phase 2 | Completed | National Center for Research Resources (NCRR) | 16 | 1994-11-01 | 2005-06-24 |
| Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma Etoposide, Rituximab, Prednisone - Diffuse Large B-Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma | Phase 2 | Completed | National Cancer Institute (NCI) | 348 | 1993-05-08 | 2025-06-22 |
Hepatic Encephalopathy (6) · Brain Diseases (2) · Constipation (2) · Fibrosis (2) · Hypertension, Portal (2) · Liver Diseases (2) · Burkitt Lymphoma (1) · Candidiasis, Vulvovaginal (1) · Dermatitis, Atopic (1) · Enterocolitis, Necrotizing (1) · Fecal Impaction (1) · Fissure in Ano (1) · Gastrointestinal Diseases (1) · Hypertension (1) · Liver Failure (1)
Norgine (2) · AVVA Pharmaceuticals Ltd. (1) · Ain Shams University (1) · All India Institute of Medical Sciences, Bhubaneswar (1) · Avva Rus, JSC (1) · Bnai Zion Medical Center (1) · CD Pharma India Pvt. Ltd. (1) · Guang'anmen Hospital of China Academy of Chinese Medical Sciences (1) · Indiana University (1) · Min-Tze LIONG (1) · National Cancer Institute (NCI) (1) · National Center for Research Resources (NCRR) (1) · Ocera Therapeutics (1) · Sherief Abd-Elsalam (1) · University of Chicago (1)
United States (5) · China (2) · Egypt (2) · India (2) · Russia (2) · United Kingdom (2) · Belarus (1) · Israel (1) · Malaysia (1)
David CA Candy, MD (2) · Andres Blei (1) · Arieh Riskin, MD (1) · Asem Elfert, Prof (1) · Asmaa A. Elrakaybi, Bachelor (1) · Daniel Olson (1) · Elliot Tapper, MD (1) · Girish Subbarao, M.D. (1) · Lyudmila Kobeleva, MD, PhD (1) · Mark J Roschewski, M.D. (1) · Mennat-Allah Elsawaf, lecturer (1) · Nickolay A. Kryuchkov, MD, PhD, MPH (1) · Paul Pockros, MD (1) · Prakash Kumar Sasmal, MBBS, MS (1)
PMID 16819379, PMID 23574119, PMID 24224624, PMID 25024303, PMID 25526462, PMID 29748435, PMID 30125215, PMID 34432874, PMID 35882475